Genomma Lab Intl Sab Ord GNMLF

$0.84 +0.08 (10.63%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
8,000
Avg volume
15,066
Day's range
$0.83 – $0.86
Shares out
—
Stochastic %K
87%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss,...

Show more

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
52 55 5081 0000
Website
https://www.genommalab.com
Address
Avenida Antonio Dovalí Jaime No. 70, Tower C, Floor 2 Office "A". Colonia Santa Fe. Álvaro Obregón Mayor's Office, Mexico City, Mexico

Latest news

No headlines yet.